IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Library CD
Volume 5, 2001 Archive
Six back issues from 2001 on one convenient archive.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $200.00


(Select Format)
Mailed CD
Instant PDF Download

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 5 No. 1 January/February 2001 Compounding for Pediatric Patients
Vol. 5 No. 2 March/April 2001 Compounding for Animals
Vol. 5 No. 3 May/June 2001 The Business of Compounding
Vol. 5 No. 4 July/August 2001 Sterile Product Compounding
Vol. 5 No. 5 September/October 2001 Bioidentical Hormone Replacement Therapy
Vol. 5 No. 6 November/December 2001 High-Tech Compounding

Volume 5, 2001 Articles

Volume 5, 2001 Articles
Title (Click for Details) Vol/Issue Page
Pediatric Compounding: Coloring Outside the Lines Vol. 5 No. 1 6
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Vol. 5 No. 1 9
Flavoring: Compounding a Treat Vol. 5 No. 1 13
Autism in Children Vol. 5 No. 1 18
Methylphenidate in the Treatment of Attention Deficit Disorders Vol. 5 No. 1 21
A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature Vol. 5 No. 1 23
Book Reviews: Stability and Formulation References Vol. 5 No. 1 25
Glycopyrrolate 1% Cream Vol. 5 No. 1 28
Topical Therapy for Localized Hyperhidrosis Vol. 5 No. 1 28
Methenamine 5% Lotion Vol. 5 No. 1 29
Compounding in History: Pediatric Considerations Vol. 5 No. 1 30
Profile of a Practice Vol. 5 No. 1 32
The Basics of Compounding Powders and Granules Vol. 5 No. 1 36
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations Vol. 5 No. 1 38
Menthol Dusting Powder-Example of Powder Formulations Vol. 5 No. 1 38
Cholestyramine 6.5% Ointment Vol. 5 No. 1 42
Ivermectin 0.8% Creme Rinse Vol. 5 No. 1 43
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel Vol. 5 No. 1 44
Lorazepam 1-mg Chewable Gummy Gels Vol. 5 No. 1 45
Metronidazole Benzoate 400-mg/5-mL Oral Suspension Vol. 5 No. 1 46
Milk of Magnesia Concentrate, Unflavored Vol. 5 No. 1 47
Natural Head Lice Repellant Spray Vol. 5 No. 1 48
Niacinamide 4% Acne Gel Vol. 5 No. 1 49
Poison Ivy Gel with 1% Hydrocortisone Vol. 5 No. 1 50
Promethazine HCl 50-mg/mL in PLO Gel Vol. 5 No. 1 51
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Vol. 5 No. 1 52
Rhodococcus Equi Pneumonia in Foals Vol. 5 No. 1 55
Sterile-Product Preparations: Mix or Buy? Vol. 5 No. 1 59
Oral Liquid Vehicles, Featured Excipient: Vol. 5 No. 1 65
Purchasing Chemicals for Pharmaceutical Compounding Vol. 5 No. 1 67
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Vol. 5 No. 1 69
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 73
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 75
Calculations Vol. 5 No. 1 78
The Use of Psychoactive Agents in Veterinary Medicine Vol. 5 No. 2 86
Benzoate or Not to Benzoate: Cats Are the Question, To Vol. 5 No. 2 89
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Vol. 5 No. 2 92
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1 Vol. 5 No. 2 95
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Vol. 5 No. 2 97
Drugs Banned for Use in Food Animals: An Explanation Vol. 5 No. 2 101
A Simplified Guide to Veterinary Compounding Vol. 5 No. 2 104
Equipment for Large-Volume Aseptic Veterinary Compounding Vol. 5 No. 2 106
Compounded Injectables for Veterinary Use Vol. 5 No. 2 107
Book Reviews: Veterinary Compounding Vol. 5 No. 2 108
From Wagon-Era Paregoric to Computer-Era Herbals Vol. 5 No. 2 112
Wish You Were Here: The Niagara Apothecary Vol. 5 No. 2 116
Profile of a Practice: Custom Rx Compounding and Natural Pharmacy Vol. 5 No. 2 118
The Basics of Compounding Emulsions, Part 1 Vol. 5 No. 2 120
Diazoxide 50-mg/mL Suspension, Veterinary Vol. 5 No. 2 126
Dimethyl Sulfoxide 50% Cream, Veterinary Vol. 5 No. 2 127
EDTA-TRIS Otic Solution V-2 (Veterinary) Vol. 5 No. 2 128
Flea Bite Gel Vol. 5 No. 2 129
Gentamicin, Polymyxin, Neomycin, and Hydrocortisone Otic Drops Vol. 5 No. 2 130
Iodine 2% in Oil Injection Vol. 5 No. 2 131
Methimazole 5-mg/0.1-mL in Pluronic Lecithin Organogel Vol. 5 No. 2 132
Sucrose Octaacetate and Capsicum Spray for Pets Vol. 5 No. 2 133
Veterinary Antiseptic Emollient Vol. 5 No. 2 134
Veterinary Oral Pastes Vol. 5 No. 2 135
Infertility Care and the Role of the Compounding Pharmacist Vol. 5 No. 2 136
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing Vol. 5 No. 2 140
Ointment Vehicles, Featured Excipient: Vol. 5 No. 2 145
Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding Vol. 5 No. 2 147
Chemical Stability of Methylprednisolone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes Vol. 5 No. 2 148
Stability of Cefepime Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 2 151
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate Vol. 5 No. 2 153
Calculations Vol. 5 No. 2 157
PostScription: Case Reports and Formulations, George Roentsch, RPh. Vol. 5 No. 2 160
Piracetam 100-mg, Ergoloid Mesylates 6-mg, and Selegiline 2.5-mg/0.2-mL Gel ("Brain Gel") Vol. 5 No. 2 160
Oxytetracycline 15-mg/0.1-mL TD Cream Vol. 5 No. 2 160
Motivation and Management: How to Build Your Business into the Job You Love Vol. 5 No. 3 166
A New Trend in Pharmacy Practice: Private Consultations Vol. 5 No. 3 170
Formulations for Success in Compounding, Part 1 Vol. 5 No. 3 174
Developing a Business Plan for a Compounding Specialty Pharmacy Vol. 5 No. 3 176
Pricing Strategies Vol. 5 No. 3 180
The Pharmacist Manpower Shortage: How to Recruit and Retain Key Employees Vol. 5 No. 3 182
Book Reviews: Business Topics for Compounding Pharmacists Vol. 5 No. 3 185
Software for the Compounding Pharmacist: A Review Vol. 5 No. 3 187
Capsule-Weighing and Trituration Calculations Vol. 5 No. 3 192
Irrigation with Piperacillin for the Treatment of Bladder Infection: A Case Study Vol. 5 No. 3 195
Compounding in History: Compounding Economics Vol. 5 No. 3 196
Stoughton's Bitters Vol. 5 No. 3 197
Tinctura Kino Composita Vol. 5 No. 3 197
The Basics of Compounding Emulsions, Part 2 Vol. 5 No. 3 198
Dry Skin and Massage Lotion-Example Vol. 5 No. 3 201
Amphotericin 5-mg/mL Nasal Inhalation Vol. 5 No. 3 204
Anthralin 1% in Lipid Crystals Cream Vol. 5 No. 3 205
Bifonazol 1% and Urea 40% in White Petrolatum Vol. 5 No. 3 206
Hand Cream, Protective Vol. 5 No. 3 207
Idoxuridine 15% in Dimethyl Sulfoxide (DMSO) Vol. 5 No. 3 208
Mitomycin 0.02% Ophthalmic Solution Vol. 5 No. 3 209
Phenytoin 100- to 400-mg Rectal Suppositories Vol. 5 No. 3 210
Tacrolimus 0.3% Ointment Vol. 5 No. 3 211
Tetracycline HCl 1% Ophthalmic Ointment Vol. 5 No. 3 212
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Vol. 5 No. 3 213
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2 Vol. 5 No. 3 214
The American Veterinary Medical Association Compounding Position Statement Vol. 5 No. 3 216
Natural Progesterone in Natural Hormone Replacement Therapy, The Role of Vol. 5 No. 3 218
Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective Vol. 5 No. 3 221
Establishing and Maintaining a Compounding Pharmacy Reference Library Vol. 5 No. 3 226
Official Water-Repelling Agents: The Official Silicones, Featured Excipient: Vol. 5 No. 3 228
Calculations Vol. 5 No. 3 229
Stability of Piperacillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 3 230
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid Vol. 5 No. 3 232
Preparation and Evaluation of Sustained Drug Release from Pluronic Polyol Rectal Suppositories Vol. 5 No. 3 234
PostScription: Compounding Pharmacists Vol. 5 No. 3 240
Quality Assurance for Sterile Products Vol. 5 No. 4 246
Sterile Compounding with Barrier-Isolation Technology Vol. 5 No. 4 254
Bacterial Endotoxins and Pyrogens Vol. 5 No. 4 259
Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices" Vol. 5 No. 4 265
Antineoplastic Agents Vol. 5 No. 4 268
Compounding Issues and Accreditation Agencies Vol. 5 No. 4 273
Book Reviews Vol. 5 No. 4 275
Sterile Compounding: Excerpts from the Reviews of Current Published Literature Vol. 5 No. 4 278
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole Vol. 5 No. 4 282
Analytical Testing Facilities and Products Vol. 5 No. 4 284
Formulations for Success, Part 2 Vol. 5 No. 4 287
Wish You Were Here: The Stabler-Leadbeater Apothecary Museum Vol. 5 No. 4 290
Basics of Compounding: Suspensions Vol. 5 No. 4 294
Suspension Structured Vehicle, USP Vol. 5 No. 4 296
Sugar-Free Suspension Structured Vehicle, USP Vol. 5 No. 4 296
Spironolactone Oral Suspension 2-mg/mL Vol. 5 No. 4 297
Progesterone Oral Suspension 40-mg/mL Vol. 5 No. 4 297
Progesterone Enema 200-mg/mL Vol. 5 No. 4 297
Xanthan Gum Oral Suspension Vehicle 0.3% Vol. 5 No. 4 297
Wound Care Mixture Vol. 5 No. 4 297
Cefazolin Ophthalmic Solution, USP 0.35- mg/mL Vol. 5 No. 4 300
Cyclopentolate HCl 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution Vol. 5 No. 4 301
Fibrin Glue Vol. 5 No. 4 302
Hyaluronidase Injection Vol. 5 No. 4 303
Hypertonic Sodium Chloride 20% Sclerotherapy Injections Vol. 5 No. 4 304
Metronidazole and Neomycin Sulfate Irrigation Solution Vol. 5 No. 4 305
Pediatric Preoperative Cocktail Injection Vol. 5 No. 4 306
Phenylephrine 0.25% Ophthalmic Solution, Preservative Free Vol. 5 No. 4 307
Sclerotherapy Injections of Phenol for Pain Management Vol. 5 No. 4 308
Tissue Plasminogen Activator (TPA) 25-mcg/100-mcL Ophthalmic Solution Vol. 5 No. 4 309
Wetting and/or Solubilizing Agents, Featured Excipient: Vol. 5 No. 4 310
Maintenance of the Cleanroom Vol. 5 No. 4 313
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration Vol. 5 No. 4 314
A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes Vol. 5 No. 4 320
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions Vol. 5 No. 4 323
Calculations Vol. 5 No. 4 325
PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor Vol. 5 No. 4 328
Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want Vol. 5 No. 5 332
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment Vol. 5 No. 5 336
Bioidentical Hormones in the Treatment of Osteoporosis Vol. 5 No. 5 339
The Value of Hormone Assessment Vol. 5 No. 5 342
Estrogen Replacement: A Review of Current Literature Vol. 5 No. 5 346
Treating Andropause: Prohormones and Hormone Metabolic Modifiers Vol. 5 No. 5 351
Bioidentical Topical Progesterone: A Survey of Patients Vol. 5 No. 5 354
Book Reviews: Hormone Replacement Therapy Vol. 5 No. 5 356
Charting Systems: Organizing Information Effectively Vol. 5 No. 5 360
Minimizing the Risk of Cholesterol-Lowering Therapy Vol. 5 No. 5 362
Compounding in History: Treatment at the Change of Life Vol. 5 No. 5 365
Flush Powder, No. 2 Vol. 5 No. 5 366
Tincture of Black Cohosh Vol. 5 No. 5 366
Lydia Pinkham's Vegetable Compound Vol. 5 No. 5 366
The Basics of Compounding: Tablets and Pills Vol. 5 No. 5 369
Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO) Vol. 5 No. 5 374
Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream Vol. 5 No. 5 375
Libido Cream Vol. 5 No. 5 376
Progesterone 50-mg/mL Clear Topical Solution Vol. 5 No. 5 377
Progesterone Low-Potency 0.0065% Topical Cream Vol. 5 No. 5 378
Sildenafil 1% Topical Cream Vol. 5 No. 5 379
Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO) Vol. 5 No. 5 380
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches Vol. 5 No. 5 381
Testosterone 25-mg/mL Clear Solution Vol. 5 No. 5 382
Testosterone 2% Scalp Lotion Vol. 5 No. 5 383
Compounding Containment Devices: Buyer Be Aware Vol. 5 No. 5 384
Capsule and Tablet Disintegrating Agents, Featured Excipient: Vol. 5 No. 5 389
Calculations Vol. 5 No. 5 391
Developing a Capsule Formulation Vol. 5 No. 5 392
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 5 No. 5 394
Assessment of the Stability of Teicoplanin in Intravenous Infusions Vol. 5 No. 5 397
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Vol. 5 No. 5 401
PostScription: Compounding Errors: Lessons Learned, Never To Be Forgotten Vol. 5 No. 5 408
High-tech Compounding: State-of-the-art Equipment Improves Products and Profit Vol. 5 No. 6 412
High-tech Rx Compliance Vol. 5 No. 6 419
High-tech Marketing Techniques Vol. 5 No. 6 420
Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures Vol. 5 No. 6 422
Nanotechnology: The Ultimate Alchemy Vol. 5 No. 6 424
Future Trends in High-technology Pharmacy Compounding Vol. 5 No. 6 426
Using Technology to Enhance the Practice of Pharmacy Vol. 5 No. 6 427
Tips for Preventing Viruses… Vol. 5 No. 6 430
Topical Secretin for the Treatment of Autism Vol. 5 No. 6 436
Wish You Were Here: Vienna, Austria Vol. 5 No. 6 438
Basics of Compounding: Parenteral Preparations Vol. 5 No. 6 441
Acetic Acid 5% Iontophoresis Solution Vol. 5 No. 6 450
Ceftazidime 20-mg/mL for Ambulatory Infusion Pump Vol. 5 No. 6 451
Dexamethasone, Lidocaine, and Verapamil Iontophoresis Solutions for Peyronie's Disease Vol. 5 No. 6 452
Doxycycline Hyclate 200-mg/mL Avian Injection Vol. 5 No. 6 453
Hydrocortisone 10% Phonophoresis Gel Vol. 5 No. 6 454
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution Vol. 5 No. 6 455
Tissue Plasminogen Activator (TPA) 0.5-mg/mL, 1.0-mg/mL, or 2.0-mg/mL for Catheter Occlusion Vol. 5 No. 6 456
Tobramycin-impregnated Polymethylmethacrylate Beads Vol. 5 No. 6 457
Total Parenteral Nutrition Solution Vol. 5 No. 6 458
Vancomycin 5-mg Sponge Disks Vol. 5 No. 6 459
Hormone Replacement Therapy, Part 2: Estrogen Defined Vol. 5 No. 6 460
The Science Behind Hormone Replacement Therapy, Part 1 Vol. 5 No. 6 462
New Perspectives on Vancomycin Use in Home Care, Part 1 Vol. 5 No. 6 465
Tablet and Lozenge Binders, Featured Excipient: Vol. 5 No. 6 471
Training Personnel Vol. 5 No. 6 474
Cross-contamination in Porcelain Mortars Vol. 5 No. 6 476
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets Vol. 5 No. 6 480
Stability of Pentobarbital Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Repackaging in Glass and Polypropylene Syringes Vol. 5 No. 6 482
Calculations Vol. 5 No. 6 485
PostScription: Lifelong Learning + Technology = Valuable Tools for the Compounding Pharmacist Vol. 5 No. 6 488